Literature DB >> 9662291

Adenocarcinoma of the uterine cervix metastatic to lymph nodes.

D E Cohn1, W A Peters, H G Muntz, R Wu, B E Greer, H K Tamimi, C W Drescher, M R Smith, J L Yon, R Schmidt, B A Goff.   

Abstract

OBJECTIVE: We set out to evaluate the prognostic factors in cervical adenocarcinoma metastatic to lymph nodes. STUDY
DESIGN: We performed a retrospective review of 40 patients with cervical adenocarcinoma and lymph node metastasis from 1976 to 1996.
RESULTS: Thirty-four patients had adenocarcinoma, and six had adenosquamous carcinoma. Median survival was 50 months. The median survival for patients with stage I disease was 69 months. Stage at diagnosis, treatment with radical hysterectomy, and receiving adjuvant therapy were associated with prolonged survival. A trend toward improved survival was noted with the use of concurrent radiation and chemotherapy as an adjuvant therapy.
CONCLUSIONS: Adenocarcinoma metastatic to the lymph nodes does not have a uniformly poor prognosis, especially with early-stage disease. Improved survival was observed with the use of adjuvant therapy, specifically the use of combined chemotherapy and radiation after radical hysterectomy. The optimal therapy in this setting is yet to be determined.

Entities:  

Mesh:

Year:  1998        PMID: 9662291     DOI: 10.1016/s0002-9378(98)70313-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Clinical and research searching on the wild side: exploring the veterinary literature.

Authors:  Kristine M Alpi; Elizabeth Stringer; Ryan S Devoe; Michael Stoskopf
Journal:  J Med Libr Assoc       Date:  2009-07

2.  (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.

Authors:  Hung-Hsueh Chou; Hsiu-Ping Chang; Chyong-Huey Lai; Koon-Kwan Ng; Swei Hsueh; Tzu-I Wu; Ming-Yu Chen; Tzu-Chen Yen; Ji-Hong Hong; Ting-Chang Chang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.